Works matching IS 1021335X AND DT 2017 AND VI 37 AND IP 4


Results: 71
    1

    CORRIGENDUM.

    Published in:
    Oncology Reports, 2017, v. 37, n. 4, p. 2522, doi. 10.3892/or.2017.5455
    Publication type:
    Article
    2
    3

    Clinical and molecular assessment of regorafenib monotherapy.

    Published in:
    Oncology Reports, 2017, v. 37, n. 4, p. 2506, doi. 10.3892/or.2017.5456
    By:
    • NAO KAKIZAWA;
    • KOICHI SUZUKI;
    • TARO FUKUI;
    • YUJI TAKAYAMA;
    • KOSUKE ICHIDA;
    • YUTA MUTO;
    • FUMI HASEGAWA;
    • FUMIAKI WATANABE;
    • RINA KIKUGAWA;
    • SHINGO TSUJINAKA;
    • KAZUSHIGE FUTSUHARA;
    • YASUYUKI MIYAKURA;
    • HIROSHI NODA;
    • TOSHIKI RIKIYAMA
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells.

    Published in:
    Oncology Reports, 2017, v. 37, n. 4, p. 2459, doi. 10.3892/or.2017.5477
    By:
    • REINA HOSHI;
    • YOSUKE WATANABE;
    • YOSHIAKI ISHIZUKA;
    • TAKAYUKI HIRANO;
    • ERI NAGASAKI-MAEOKA;
    • SHINSUKE YOSHIZAWA;
    • SHOTA UEKUSA;
    • HIROYUKI KAWASHIMA;
    • KENSUKE OHASHI;
    • KIMINOBU SUGITO;
    • NOBORU FUKUDA;
    • HIROKI NAGASE;
    • MASAYOSHI SOMA;
    • TOSHINORI OZAKI;
    • TSUGUMICHI KOSHINAGA;
    • KYOKO FUJIWARA
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50